Objective: To study infliximab and etanercept in the treatment of refractory juvenile idiopathic arthritis (JIA). Methods: In a non-randomised, prospective, open label study, 24 patients (mean age ...

Infliximab, etanercept and adalimumab can induce remission and prevent both clinical and radiological disease progression in rheumatoid arthritis with significant improvement in patients' symptoms ...

The cost per ACR50/70 response ratio favored the labeled dose of etanercept compared with both the low (3 mg/kg every 8 weeks) and high (10 mg/kg every 4 weeks) maintenance doses of infliximab.

Index cases were 44 patients whose infliximab doses had been increased. Controls were patients treated with infliximab without dose increase (n = 44), and patients treated with etanercept (n = 36).

Dose escalations were more frequent with ustekinumab in patients with psoriasis compared with adalimumab and etanercept, highlighting varied outcomes for dose optimization in psoriasis management.

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

Celltrion Healthcare’s subcutaneous (SC) formulation of its infliximab biosimilar, codenamed CT-P13 SC, looks set to launch in Europe in the coming months in rheumatoid arthritis, after a ...

Erelzi (etanercept-szzs) has been approved in all ... The FDA has already approved Pfizer's Inflectra (infliximab-dyyb) and Sandoz's Zarzio (filgrastim-sndz), which are near copies of J&J's ...

The podocytopathies, including minimal-change nephropathy, focal segmental glomerulosclerosis, collapsing glomerulopathy, and diffuse mesangial sclerosis, involve diverse types of injury to ...

We investigated whether patients with inflammatory bowel disease treated with infliximab have attenuated serological responses to a single dose of a SARS-CoV-2 vaccine. Design Antibody responses and ...

Objective To evaluate the impact of methotrexate (MTX) dosage on clinical, functional and quality of life outcomes in patients with rheumatoid arthritis (RA) from two previous etanercept (ETN) trials ...